Clinical Trials Directory

Trials / Sponsors / Frontier Biotechnologies Inc.

Frontier Biotechnologies Inc.

Industry · 13 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingAn Bioequivalence Study of Loxoprofen Sodium Patches in Healthy Volunteers
Osteoarthritis, Muscle Pain, Swelling Muscle
Phase 12024-07-01
UnknownEvaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19
Mild to Moderate COVID-19
Phase 2 / Phase 32023-01-04
CompletedA Study of FB2001 for Inhalation in Healthy Chinese Adults
COVID-19 Pandemic
Phase 12022-10-21
UnknownEvaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT S
COVID-19
Phase 2 / Phase 32022-09-14
CompletedStudy to Evaluate Pharmacokinetic and Safety of Albuvirtide Between Intravenous Drip and Intravenous Injection
HIV/AIDS
Phase 12022-02-16
CompletedA Bridging Study of FB2001 in Healthy Subjects
COVID-19
Phase 12021-12-29
UnknownAlbuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 Infection
HIV/AIDS
Phase 22021-11-30
UnknownAlbuvirtide in Combination With 3BNC117 in Virologically Suppressed Subjects With HIV-1 Infection
HIV/AIDS
Phase 22021-05-01
CompletedThe Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection
Covid19
Phase 12021-03-17
CompletedTolerability, Safety and Pharmacokinetics of a Topical AB001 Patch in Healthy Subjects
Chronic Low Back Pain
Phase 12019-06-24
UnknownAlbuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects
HIV-1-infection
Phase 22018-12-17
CompletedA Study of a Topical Patch (AB001) in Patients With Chronic Low Back Pain
Chronic Low Back Pain
Phase 22015-04-01
CompletedTest Albuvirtide in Experienced Patients
HIV Infections, AIDS
Phase 32014-02-19